Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants

Muller, William; Madhi, Shabir; Seoane Nunez, Beatriz; Baca Cots, Manuel; Bosheva, Miroslava; Dagan, Ron; Hammitt, Laura; Llapur, Conrado; Novoa, Jose; Llorens, Xavier; Grenham, Amy; Kelly, Elizabeth; Mankad, Vaishali; Shroff, Manish; Takas, Therese; Leach, Amanda; Villafana, AYLA

doi:10.1056/nejmc2214773

Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants

Muller W. J., Madhi S. A., Seoane Nunez B., Baca Cots M., Bosheva M., Dagan R., ...More

NEW ENGLAND JOURNAL OF MEDICINE, vol.388, no.16, pp.1533-1534, 2023 (SCI-Expanded, Scopus)

Publication Type: Article / Letter
Volume: 388 Issue: 16
Publication Date: 2023
Doi Number: 10.1056/nejmc2214773
Journal Name: NEW ENGLAND JOURNAL OF MEDICINE
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, Abstracts in Social Gerontology, AgeLine, BIOSIS, CAB Abstracts, Chemical Abstracts Core, CINAHL, Educational research abstracts (ERA), Food Science & Technology Abstracts, Gender Studies Database, International Pharmaceutical Abstracts, MLA - Modern Language Association Database, Public Affairs Index, Veterinary Science Database, Nature Index
Page Numbers: pp.1533-1534
Kocaeli University Affiliated: No

Abstract

Nirsevimab to Prevent RSV Illness in InfantsNirsevimab, a monoclonal antibody targeting respiratory syncytial virus, protected against RSV-associated hospitalization and severe lower respiratory tract infection in term and late-preterm infants.